Michael A. Caligiuri
| Michael A. Caligiuri | |
|---|---|
| Born |
January 8, 1956[1] Buffalo, New York |
| Citizenship | American |
| Fields | oncology |
| Institutions | |
| Alma mater | |
| Spouse | Ana Maria de Jesús Caligiuri [1] |
| Children | 3 |
Michael A. Caliguiri is the CEO of The James Cancer Hospital and Solove Research Institute and Director of the OSU Comprehensive Cancer Center, as well as Professor of Molecular Virology, Immunology, Medical Genetics, and Internal Medicine and vice president for health sciences at The Ohio State University.[2] He was elected president of the American Association for Cancer Research for 2016–2017.[3]
He is also the chair of cancer research for the John L. Marakas Nationwide Insurance Enterprise Foundation, a member of the Lymphoma Research Foundation Scientific Advisory Board, and chair of the National Cancer Policy Forum, Institute of Medicine.[4]
Caligiuri has served on committees and advisory boards of many organizations, including but not limited to the New York State councils on stem cells and transplantation, USA National Cancer Institute-Sponsored Cooperative Oncology Group, United States of America President's Cancer Panel, Transplantation Society, Society for Natural Immunity, National Institute of Allergy and Infectious Disease, National Cancer Institute, Lymphoma Research Institute, Leukemia Society of America, Institute of Medicine, Friends of Cancer Research, Cure for Lymphoma Foundation, Association of American Cancer Institutes, American Society of Hematology, American Society of Clinical Oncology, American Cancer Society, Association for Research of Childhood Cancer, Memorial Sloan Kettering Cancer Center, Mayo Clinic Cancer Center, and Fox Chase Cancer Center.[1] His work has been funding by the American Cancer Society, Buffalo Medical Foundation, National Cancer Institute, Dr. Louis Sklarow Memorial Fund, Howard Hughes Medical Institute, Leukemia Society of America, Lymphoma Research Foundation, OHIO Third Frontier, Leukemia & Lymphoma Society, and others.[1]
Caligiuri was deputy director of the James Cancer Hospital and Solove Research Institute from 2003 to 2007, director (2000–2007) and co-director (1997–2000) of the Division of Hematology and Oncology, Department of Internal Medicine, associate director for clinical research at The Ohio State University Comprehensive Cancer Center from 1997 to 2003, and director of the Hematology/Oncology Fellowship Program from 1997 to 2004. He was an attending physician at Roswell Park Memorial Institute from 1990 to 1997 and a professor in the Departments of Medicine and Microbiology/Immunology at Roswell Park Cancer Institute and State University of New York at Buffalo School of Medicine from 1993 to 1997.[5]
The Caligiuri laboratory focuses on natural killer cells, the Epstein-Barr virus's involvement in tumorigenesis, and hematological cancers such as lymphoma and leukemia.[6]
He is one of the most highly compensated employees at OSU, earning over a million dollars per year.[7]
Honors and Awards
- President, Society for Natural Immunity (2015–2017)[5]
- chair, National Cancer Policy Forum, Institute of Medicine (2014–present)
- recipient, National Cancer Institute Director’s Service Award (2012)
- councillor and Executive Committee member, American Society of Hematology (2011–2015)
- recipient, MERIT Award, National Cancer Institute (2010)
- member, Board of Scientific Advisors, Lymphoma Research Foundation (2010–present)
- president, Association of American Cancer Institutes (2009–2011)
- member, Board of Scientific Advisors, National Cancer Institute (2008–2012)
- elected fellow, Alpha Omega Alpha Honor Medical Society (2008)
- recipient, John Wayne Clinical Research Award, Society of Surgical Oncologists (2008)
- elected member, Association of American Physicians (2004)
- elected fellow, American Association for the Advancement of Science (2003)
- vice chair, Scientific Advisory Board, Cure for Lymphoma Foundation (2000–2004)
- recipient, Emil J Freireich Award in Clinical Cancer Research, University of Texas MD Anderson Cancer Center (1999)
- elected member, American Society for Clinical Investigation (1998)
- elected fellow, American College of Physicians (1998)
- member, AACR board of directors (2013–2016)
- chairperson, AACR Annual Meeting Program Committee (2009)
- chairperson (2002) and member (2001), AACR Scientific Committee
- member, AACR Science Policy and Legislative Affairs Committee (2001–2004, 2006–2009, 2012–2015)
- member, AACR Clinical and Translational Cancer Research Committee (2001–2004, 2012–present)
- recipient, American Cancer Society John P. Minton Hero of Hope Research Champion Medal of Honor Award (2004)
Refefences
- 1 2 3 4 https://osuwmcdigital.osu.edu/sitetool/sites/intmedhematologypublic/documents/Caligiuri_CV_03_01_2012.pdf
- ↑ "Michael Caligiuri, MD :: Internal Medicine Division of Hematology :: The Ohio State University :: Columbus, OH". internalmedicine.osu.edu. Retrieved 2016-11-18.
- ↑ "Michael A. Caligiuri, MD, Named American Association for Cancer Research President-Elect 2016-2017". aacr.org. Retrieved 2016-11-18.
- ↑ "Featured LRF Reseacher: Michael A. Caligiuri, MD - Lymphoma Research Foundation". lymphoma.org. Retrieved 2016-11-18.
- 1 2 "President-Elect Candidate Profile: Michael A. Caligiuri". aacr.org. Retrieved 2016-11-18.
- ↑ "Caligiuri Lab | OSUCCC – James". cancer.osu.edu. Retrieved 2016-11-18.
- ↑ "Top 25 List Highest-Paid Public Officials-OSU - Columbus Business First". bizjournals.com. Retrieved 2016-11-18.